De novo PMP2mutations in families with type 1 Charcot–Marie–Tooth disease
Author(s) -
William W. Motley,
Paulius Palaima,
Sabrina W. Yum,
Michael Gonzalez,
Feifei Tao,
Julia Wanschitz,
Alleene V. Strickland,
Wolfgang N. Löscher,
Els De Vriendt,
Stefan Koppi,
Līvija Medne,
Andreas Janecke,
Albena Jordanova,
Stephan Züchner,
Steven S. Scherer
Publication year - 2016
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/aww055
Subject(s) - proband , genetics , exome sequencing , tooth disease , peripheral myelin protein 22 , biology , mutation , medicine , gene , phenotype
We performed whole exome sequencing on a patient with Charcot-Marie-Tooth disease type 1 and identified a de novo mutation in PMP2, the gene that encodes the myelin P2 protein. This mutation (p.Ile52Thr) was passed from the proband to his one affected son, and segregates with clinical and electrophysiological evidence of demyelinating neuropathy. We then screened a cohort of 136 European probands with uncharacterized genetic cause of Charcot-Marie-Tooth disease and identified another family with Charcot-Marie-Tooth disease type 1 that has a mutation affecting an adjacent amino acid (p.Thr51Pro), which segregates with disease. Our genetic and clinical findings in these kindred demonstrate that dominant PMP2 mutations cause Charcot-Marie-Tooth disease type 1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom